This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DeVries, A. F. Articles by Lukas, P. Search for Related Content PubMed PubMed Citation Articles by DeVries, A. F. Articles by Lukas, P.

Tumor Microcirculation Evaluated by Dynamic Magnetic Resonance Imaging Predicts Therapy Outcome for Primary Rectal Carcinoma¹

Departments of Radiotherapy and Radiooncology [A. F. D., P. L.], Magnetic Resonance [C. K., W. J.], Pathology [A. K.], Surgery [D. Ö.], and Biostatistics [K-P. P.], University of Innsbruck, 6020 Innsbruck, Austria; and GSF Research Center for Environment and Health, Institute for Radiation Biology [T. G.], and Federal Office for Radiation Protection (BfS), Institute of Radiation Hygiene [J. G., G. B.], 85764 Neuherberg, Germany

Contrast enhanced dynamic studies of malignant tumors performed by computed tomography or magnetic resonance imaging (MRI) are increasingly applied to characterize tumor microcirculation for the prediction of therapy outcome. The aim of our study was to correlate perfusion index (PI) values determined in primary rectal carcinoma before chemoradiation with therapy outcome.

In 17 patients with clinically staged T3 primary rectal carcinoma, dynamic MRI was performed before the onset of therapy using an ultrafast T1-mapping sequence. On the basis of the acquired data sets, PI values were calculated on a pixel-by-pixel basis. To characterize the heterogeneity of tumor microcirculation, relative cumulative frequency histograms of PI values within the tumors were computed. Subsequent resection of the tumors allowed correlating PI with histopathological classification.

In 12 of 17 patients, T-downstaging as a response to therapy was found, whereas in the remaining 5 patients no therapy response was observed after chemoradiation. A statistically significant difference between both groups was found for the mean PI (P < 0.001; 8.5 ± 1.7 ml/min/100 g versus 11.4 ± 0.7 ml/min/100 g). Analyzing the cumulative frequency histograms for both groups revealed an optimal discrimination for a PI value of 12.6 ml/min/100 g. The fraction of pixels in the tumor with PI values larger than 12.6 ml/min/100 g was significantly different (P < 0.001) between therapy-responding (3 ± 3.6%) and therapy-nonresponding tumors (21 ± 4.3%).

The results indicate either a reduced supply of nutrients as well as chemotherapeutic agents attributable to increased shunt flow or highly aggressive tumor cell clusters characterized by increased angiogenic activity. Noninvasive PI measurements by dynamic MRI in rectal carcinoma before therapy seem to be of predictive value for therapy outcome in patients scheduled for preoperative chemoradiation.

This article has been cited by other articles:

				D. Vriens, H. W.M. van Laarhoven, J. J.A. van Asten, P. F.M. Krabbe, E. P. Visser, A. Heerschap, C. J.A. Punt, L.-F. de Geus-Oei, and W. J.G. Oyen Chemotherapy Response Monitoring of Colorectal Liver Metastases by Dynamic Gd-DTPA-Enhanced MRI Perfusion Parameters and 18F-FDG PET Metabolic Rate J. Nucl. Med., November 1, 2009; 50(11): 1777 - 1784. [Abstract] [Full Text] [PDF]

				W. R. Jarnagin, L. H. Schwartz, D. H. Gultekin, M. Gonen, D. Haviland, J. Shia, M. D'Angelica, Y. Fong, R. DeMatteo, A. Tse, et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival Ann. Onc., September 1, 2009; 20(9): 1589 - 1595. [Abstract] [Full Text] [PDF]

				B. Turkbey, H. Kobayashi, M. Ogawa, M. Bernardo, and P. L. Choyke Imaging of Tumor Angiogenesis: Functional or Targeted? Am. J. Roentgenol., August 1, 2009; 193(2): 304 - 313. [Abstract] [Full Text] [PDF]

				M. Oostendorp, M. J. Post, and W. H. Backes Vessel Growth and Function: Depiction with Contrast-enhanced MR Imaging Radiology, May 1, 2009; 251(2): 317 - 335. [Abstract] [Full Text] [PDF]

				S. D. Allen, A. R. Padhani, A. S. Dzik-Jurasz, and R. Glynne-Jones Rectal Carcinoma: MRI with Histologic Correlation Before and After Chemoradiation Therapy Am. J. Roentgenol., February 1, 2007; 188(2): 442 - 451. [Abstract] [Full Text] [PDF]

				C. Rodel and R. Sauer In Reply: J. Clin. Oncol., March 10, 2006; 24(8): 1320 - 1321. [Full Text] [PDF]

				C. Kremser, T. R. Trieb, W. Judmaier, A. F. DeVries, D. Sahani, S. Kalva, and P. F. Hahn Assessing Tumor Perfusion and Treatment Response in Rectal Cancer Radiology, February 1, 2006; 238(2): 756 - 757. [Full Text] [PDF]

				D. Sahani, S. Kalva, and P. F. Hahn Response Radiology, February 1, 2006; 238(2): 757 - 757. [Full Text] [PDF]

				H. W. M. van Laarhoven, L.-F. de Geus-Oei, B. Wiering, J. Lok, M. Rijpkema, J. H. A. M. Kaanders, P. F. M. Krabbe, T. Ruers, C. J. A. Punt, A. J. van der Kogel, et al. Gadopentetate Dimeglumine and FDG Uptake in Liver Metastases of Colorectal Carcinoma as Determined with MR Imaging and PET Radiology, October 1, 2005; 237(1): 181 - 188. [Abstract] [Full Text] [PDF]

				D. V. Sahani, S. P. Kalva, L. M. Hamberg, P. F. Hahn, C. G. Willett, S. Saini, P. R. Mueller, and T.-Y. Lee Assessing Tumor Perfusion and Treatment Response in Rectal Cancer with Multisection CT: Initial Observations Radiology, March 1, 2005; 234(3): 785 - 792. [Abstract] [Full Text] [PDF]

				S. Rehman and G. C. Jayson Molecular Imaging of Antiangiogenic Agents Oncologist, February 1, 2005; 10(2): 92 - 103. [Abstract] [Full Text] [PDF]

				L. H. Dennis Cheong, C. C. Tchoyoson Lim, and T. S. Koh Dynamic Contrast-enhanced CT of Intracranial Meningioma: Comparison of Distributed and Compartmental Tracer Kinetic Models--Initial Results Radiology, September 1, 2004; 232(3): 921 - 930. [Abstract] [Full Text] [PDF]

				A R Padhani MRI for assessing antivascular cancer treatments Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80. [Abstract] [Full Text] [PDF]

				M. V. Knopp, H. von Tengg-Kobligk, and P. L. Choyke Functional Magnetic Resonance Imaging in Oncology for Diagnosis and Therapy Monitoring Mol. Cancer Ther., April 1, 2003; 2(4): 419 - 426. [Abstract] [Full Text] [PDF]